Intracranial Distal Access Catheter in Neurointerventional Therapy
A Clinical Study on the Safety and Effectiveness of Intracranial Distal Access Catheter in Neurointerventional Therapy
1 other identifier
observational
114
1 country
6
Brief Summary
The study objective is to evaluate the safety and effectiveness of Intracranial Distal Access Catheter in neurointerventional therapy.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Dec 2023
Shorter than P25 for all trials
6 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 7, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
March 1, 2024
CompletedFirst Submitted
Initial submission to the registry
April 15, 2025
CompletedFirst Posted
Study publicly available on registry
May 25, 2025
CompletedMay 25, 2025
May 1, 2025
3 months
April 15, 2025
May 19, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
Technical success rate
It is defined as the proportion of subjects where Intracranial Distal Access Catheter can reach the expected position to successfully deliver the device and meet the treatment needs. Special note: If the patient uses more than one Intracranial Distal Access Catheters during the procedure, as long as any Intracranial Distal Access Catheter is delivered successfully, the patient is considered to achieve successful delivery with Intracranial Distal Access Catheter. Technical success rate (%) = number of patients successfully delivered/number of patients analyzed \* 100%
immediately after procedure
Secondary Outcomes (3)
Catheter delivery success rate
immediately after procedure
Incidence of device-related adverse events
from the procedure to patients discharged from the hospital, anticipated average 5 days
Incidence of device-related serious adverse events
from the procedure to patients discharged from the hospital, anticipated average 5 days
Other Outcomes (3)
Device operation performance (device compatibility)
intra-procedure
Device operation performance (supporting capability)
intra-procedure
Device operation performance (pushing resistance)
intra-procedure
Study Arms (1)
Subjects who using the Intracranial Distal Access Catheter to complete the procedure
Patients with mechanical thrombectomy for acute ischemic stroke, treatment of intracranial aneurysms and other ischemic and hemorrhagic diseases, requiring the use of Intracranial Distal Access Catheter to complete the procedure (such as poor vascular access conditions, lesions located in secondary or higher branches of cerebral vessels, inability of conventional guiding catheters in place and providing effective support. Treatment with Flow-divert devices, covered stents, etc.)
Interventions
Patients with mechanical thrombectomy for acute ischemic stroke, treatment of intracranial aneurysms and other ischemic and hemorrhagic diseases, requiring the use of Intracranial Distal Access Catheter(X-Track) to complete the procedure
Eligibility Criteria
Patients with mechanical thrombectomy for acute ischemic stroke, treatment of intracranial aneurysms and other ischemic and hemorrhagic diseases, requiring the use of Intracranial Distal Access Catheter to complete the procedure (such as poor vascular access conditions, lesions located in secondary or higher branches of cerebral vessels, inability of conventional guiding catheters in place and providing effective support. Treatment with Flow-divert devices, covered stents, stent grafts, etc.)
You may qualify if:
- Age = 18-80 years old.
- Patients with mechanical thrombectomy for acute ischemic stroke, treatment of intracranial aneurysms and other ischemic and hemorrhagic diseases, requiring the use of Intracranial Distal Access Catheter to complete the procedure (such as poor vascular access conditions, lesions located in secondary or higher branches of cerebral vessels, inability of conventional guiding catheters in place and providing effective support. Treatment with Flow-divert devices, covered stents, stent grafts, etc.)
- Patients agree to participate in the study and sign the informed consent form.(only prospective enrolled patients)
You may not qualify if:
- Intracranial Distal Access Catheter is used during the interventional therapy of non-neurovascular diseases, such as peripheral vascular and coronary artery diseases.
- Interventional procedure is performed with other distal catheters or devices with the same function before using Intracranial Distal Access Catheter.
- Ordinary guiding catheters can be used to establish access to complete the procedure without the use of Intracranial Distal Access Catheter.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (6)
Zhangzhou Municipal Hospital of Fujian Province
Zhangzhou, Fujian, China
Jiangmen Xinhui District People's Hospital
Jiangmen, Guangdong, China
Xinxiang Central Hospital
Xinxiang, Henan, China
The Sixth People's Hospital of Nantong
Nantong, Jiangsu, China
People's Hospital of Rizhao
Rizhao, Shandong, China
The Affiliated Hospital of Yunnan University
Kunming, Yunnan, China
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
JUN DONG, Associate chief physician
Rizhao People's Hospital
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- OTHER
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
April 15, 2025
First Posted
May 25, 2025
Study Start
December 7, 2023
Primary Completion
March 1, 2024
Study Completion
March 1, 2024
Last Updated
May 25, 2025
Record last verified: 2025-05